ArticleAssay and drug development technologies2015

HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.

Paul A Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.